AU2187595A – Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction
– Google Patents
AU2187595A – Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction
– Google Patents
Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction
Info
Publication number
AU2187595A
AU2187595A
AU21875/95A
AU2187595A
AU2187595A
AU 2187595 A
AU2187595 A
AU 2187595A
AU 21875/95 A
AU21875/95 A
AU 21875/95A
AU 2187595 A
AU2187595 A
AU 2187595A
AU 2187595 A
AU2187595 A
AU 2187595A
Authority
AU
Australia
Prior art keywords
diagnosis
diseases
treatment
methods
signal transduction
Prior art date
1994-03-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21875/95A
Inventor
John E Ladbury
Irit Lax
Mark A Lemmon
Ben Lewis Margolis
Joseph Schlessinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University Medical Center
Original Assignee
New York University Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1994-03-14
Filing date
1995-03-13
Publication date
1995-10-03
1995-03-13
Application filed by New York University Medical Center
filed
Critical
New York University Medical Center
1995-10-03
Publication of AU2187595A
publication
Critical
patent/AU2187595A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
C07K14/475—Growth factors; Growth regulators
C07K14/485—Epidermal growth factor [EGF] (urogastrone)
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
C07K14/475—Growth factors; Growth regulators
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
AU21875/95A
1994-03-14
1995-03-13
Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction
Abandoned
AU2187595A
(en)
Applications Claiming Priority (5)
Application Number
Priority Date
Filing Date
Title
US21223494A
1994-03-14
1994-03-14
US212234
1994-03-14
US25578594A
1994-06-08
1994-06-08
US255785
1994-06-08
PCT/US1995/003452
WO1995025166A1
(en)
1994-03-14
1995-03-13
Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction
Publications (1)
Publication Number
Publication Date
AU2187595A
true
AU2187595A
(en)
1995-10-03
Family
ID=26906921
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU21875/95A
Abandoned
AU2187595A
(en)
1994-03-14
1995-03-13
Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction
Country Status (5)
Country
Link
EP
(1)
EP0797662B1
(en)
AU
(1)
AU2187595A
(en)
CA
(1)
CA2187781A1
(en)
DE
(1)
DE69535707T2
(en)
WO
(1)
WO1995025166A1
(en)
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU701733B2
(en)
*
1995-05-02
1999-02-04
Garvan Institute Of Medical Research
GDU, a novel signalling protein
Families Citing this family (5)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US7625859B1
(en)
2000-02-16
2009-12-01
Oregon Health & Science University
HER-2 binding antagonists
US7393823B1
(en)
1999-01-20
2008-07-01
Oregon Health And Science University
HER-2 binding antagonists
US7396810B1
(en)
2000-08-14
2008-07-08
Oregon Health Sciences University
Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
EP2346526A2
(en)
2008-09-22
2011-07-27
Massachusetts Institute of Technology
Compositions of and methods of using ligand dimers
WO2011119836A1
(en)
2010-03-24
2011-09-29
Massachusetts Institute Of Technology
Methods and compositions for cardioprotection and cardioregeneration
Family Cites Families (2)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5183805A
(en)
*
1990-08-13
1993-02-02
Board Of Regents, The University Of Texas System
Bioactive egf peptides for promotion of tissue regeneration and cancer therapy
NZ252486A
(en)
*
1992-04-29
1997-08-22
Univ Georgetown
Blocking peptides capable of binding to ligands of the epidermal growth factor receptor (erbb-2) and their use in detecting such ligands
1995
1995-03-13
EP
EP95914759A
patent/EP0797662B1/en
not_active
Expired – Lifetime
1995-03-13
DE
DE69535707T
patent/DE69535707T2/en
not_active
Expired – Fee Related
1995-03-13
AU
AU21875/95A
patent/AU2187595A/en
not_active
Abandoned
1995-03-13
CA
CA 2187781
patent/CA2187781A1/en
not_active
Abandoned
1995-03-13
WO
PCT/US1995/003452
patent/WO1995025166A1/en
active
IP Right Grant
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU701733B2
(en)
*
1995-05-02
1999-02-04
Garvan Institute Of Medical Research
GDU, a novel signalling protein
Also Published As
Publication number
Publication date
DE69535707T2
(en)
2009-05-07
DE69535707D1
(en)
2008-03-27
EP0797662A1
(en)
1997-10-01
CA2187781A1
(en)
1995-09-21
WO1995025166A1
(en)
1995-09-21
EP0797662B1
(en)
2008-02-13
Similar Documents
Publication
Publication Date
Title
US5443960B1
(en)
1999-01-12
Method for the diagnosis of blood coagulation disorders
AU4582797A
(en)
1998-04-02
Methods for treatment of retinal diseases
AU4160396A
(en)
1996-06-06
Method for diagnosis of thrombotic disorders
AUPM864894A0
(en)
1994-11-03
Treatment of bowel-dependent neurological disorders
GB2305605B
(en)
2000-01-12
Pipecolic acid derivatives for the treatment of neurological disorders
AU4594796A
(en)
1996-06-19
System and method for diagnosis of living tissue diseases
AU3201095A
(en)
1996-02-22
Substituted thiazoles for the treatment of inflammation
AUPN205095A0
(en)
1995-04-27
Diagnosis of neuromuscular dysfunction
AU4297685A
(en)
1985-11-28
Compositions for the allevation, treatment and diagnosis of arthritic disease and related conditions
AU2639695A
(en)
1996-01-04
Novel uses of triplex forming oligonucleotides for the treatment of human diseases
AU7905894A
(en)
1995-08-03
Treatment of poultry
AU698509B2
(en)
1998-10-29
Compositions for the treatment of rheumatoid-based arthritic diseases
EP0736761A3
(en)
1998-01-21
Engine diagnostic monitor
AU2424895A
(en)
1995-11-29
Substituted spirodienes for the treatment of inflammation
AU6264596A
(en)
1996-12-30
Diagnosis, prognosis and monitoring of angiogenesis dependen t diseases
AU7310896A
(en)
1997-05-07
Use of nitroflavonoids for the treatment of anxiety
AU2187595A
(en)
1995-10-03
Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction
AU3596797A
(en)
1998-02-02
Methods for the treatment of apolipoprotein e related diseases
AUPN118095A0
(en)
1995-03-09
Improved process for the refining of sugar
AU2233495A
(en)
1995-10-23
Treatment or diagnosis of abnormal signal transduction disorders
AU1831195A
(en)
1995-08-01
Methods and compositions for treatment and diagnosis of alzheimer disease and other disorders
AU5699396A
(en)
1996-11-29
Compositions for the treatment of skin conditions
AU4754496A
(en)
1996-07-24
Methods for diagnosis and treatment of mdk1 signal transduction disorders
AU6460696A
(en)
1997-01-22
Use of n-cyclohexyl benzamides for treating bowel disorders
AU5430894A
(en)
1994-06-08
Diagnosis of eye disorders
None